Biliary Tract Neoplasms
📧 Sign up to get email alerts when something new happens for Biliary Tract Neoplasms.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-06-16EMA Authorised: Ziihera (zanidatamab) — Jazz Pharmaceuticals Ireland Limited
ZaniDatamab (zanidatamab) has been authorised by EMA for biliary tract neoplasms with conditional approval and orphan designation.
-
EMA approval · 2025-12-17EMA Authorised: Ziihera (zanidatamab) — Jazz Pharmaceuticals Ireland Limited
EMA authorised zanidatamab (Ziihera) for biliary tract neoplasms under conditional approval and orphan medicine designation.